Skip to main content

Table 5 Double-blind placebo-controlled food challenge (DBPCFC) and initial food escalation (IFE) schedule

From: Protocol for a double-blind, randomized controlled trial on the dose-related efficacy of omalizumab in multi-food oral immunotherapy

Protein amount in mg (1:1:1)

0.3

1

3

10

30

100

300a

600

1050

1500

Observation time (min)

30

30

30

30

30

30

30b

30

30

120

  1. aLast step for DBPCFC
  2. bobserved for 2 h during DBPCFC